...
首页> 外文期刊>BMC Neurology >A systematic review and meta-analysis to evaluate the diagnostic accuracy of recognition of stroke in the emergency department (ROSIER) scale
【24h】

A systematic review and meta-analysis to evaluate the diagnostic accuracy of recognition of stroke in the emergency department (ROSIER) scale

机译:系统审查和荟萃分析,以评估急诊部(Rosier)规模中风的诊断准确性

获取原文
           

摘要

The present study aims to evaluate the performance and the clinical applicability of the Recognition of Stroke in the Emergency Department (ROSIER) scale via systematic review and meta-analysis. Electronic databases of Pubmed and Embase were searched between 1st January 2005 (when ROSIER developed) and 8th May 2020. Studies that evaluated the diagnostic accuracy of the ROSIER scale were included. The sensitivity, specificity, diagnostic odds ratio (DOR), and area under the curve (AUC) were combined using a bivariate mixed-effects model. Fagan nomogram was used to evaluate the clinical applicability of the ROSIER scale. A total of 14 studies incorporating 15 datasets were included in this meta-analysis. The combined sensitivity, specificity, DOR and AUC were 0.88 [95% confidence interval (CI): 0.83–0.91], 0.66 (95% CI: 0.52–0.77), 13.86 (95% CI, 7.67–25.07) and 0.88 (95% CI, 0.85–0.90), respectively. Given the pre-test probability of 60.0%, Fagan nomogram suggested the post-test probability was increased to 79% when the ROSIER was positive. In comparison, it was decreased to 22% when ROSIER was negative. Subgroup analysis showed that the pooled sensitivity of ROSIER in the European population was higher than that in Asia. In contrast, the pooled specificity was not significantly different between them. Moreover, results also suggested the male-to-female ratio?≤?1.0 subgroup, prehospital setting subgroup, and other trained medical personnel subgroup had significantly higher sensitivity compared with their counterparts. At the same time, no significant differences were found in the pooled specificity between them. ROSIER is a valid scale with high clinical applicability, which has not only good diagnostic accuracy in Europe but also shows excellent performance in Asia. Moreover, the ROSIER scale exhibits good applicability in prehospital settings with other trained medical personnel.
机译:本研究旨在通过系统审查和荟萃分析来评估急诊部(Rosier)规模识别中风的绩效和临床适用性。在2005年1月1日(rosier开发)和2020年5月8日之间搜查了PubMed和Embase的电子数据库。评估了罗西尔规模的诊断准确性的研究。使用双变型混合效应模型合并曲线(AUC)下的敏感性,特异性,诊断差率比(DOR)和面积。 FAGAN NOMAROM用于评估ROSIER规模的临床适用性。在该荟萃分析中,共用了包含15个数据集的14项研究。合并的敏感性,特异性,DOR和AUC为0.88 [95%置信区间(CI):0.83-0.91],0.66(95%CI:0.52-0.77),13.86(95%CI,7.67-25.07)和0.88(95个%CI,0.85-0.90)分别。鉴于预测概率为60.0%,Fagan Rommogram建议当兰斯尔阳性时,测试后概率增加到79%。相比之下,当罗西尔阴性阴性时,它减少到22%。亚组分析表明,欧洲人口中罗西尔的汇集敏感性高于亚洲。相比之下,它们之间的汇集特异性并没有显着差异。此外,结果还提出了雄性与女性的比例?≤≤1.0亚群,预播种设置亚组和其他培训的医疗人员亚组与他们的对应物相比具有显着更高的灵敏度。与此同时,在它们之间的汇总特异性中没有发现显着差异。 Rosier是一种有效的规模,具有高临床适用性,不仅在欧洲的良好诊断准确性,而且在亚洲也表现出优异的表现。此外,Rosier规模在与其他培训的医务人员的预孢子环境中表现出良好的适用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号